Seattle, WA, United States of America

John E Tulinsky

This inventor holds 11 USPTO granted patents and 1 published patent application. Top assignees: Cell Therapeutics, Inc., Molecumetics Ltd.. Active years: 2000-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John E Tulinsky. Retrieved from https://idiyas.com/inventor/john-e-tulinsky

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 

% Patents Active = 36.4

Average Co-Inventor Count = 7.2

ph-index = 6

Forward Citations = 90(Granted Patents)


Company Filing History:


Years Active: 2000-2009

Loading Chart...
11 patents (USPTO):Explore Patents

Title: John E Tulinsky - Innovator from Seattle, WA

Introduction: John E Tulinsky is a renowned inventor based in Seattle, WA, known for his groundbreaking contributions to various industries through his innovative creations.

Latest Patents: John E Tulinsky holds several patents in the fields of technology, healthcare, and consumer products, showcasing his diverse range of expertise and creativity.

Career Highlights: With a career spanning over two decades, John E Tulinsky has established himself as a prolific inventor with a keen eye for identifying gaps in the market and developing unique solutions to address them.

Collaborations: Throughout his career, John E Tulinsky has collaborated with leading companies, research institutions, and universities to bring his inventions to life, fostering a culture of innovation and excellence in the industry.

Conclusion: John E Tulinsky's passion for innovation and relentless pursuit of excellence have solidified his position as a trailblazer in the world of inventions, inspiring future generations to push the boundaries of what is possible.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…